Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|June 10, 2020
Changes in LCI in F508del/F508del patients treated with lumacaftor/ivacaftor: Results from the prospect studyMichelle Shaw, Umer Khan, John P Clancy, et al.
The Journal of Biological Chemistry|January 5, 2002
Regulation of the epithelial sodium channel by serine proteases in human airwaysScott H Donaldson, Andrew Hirsh, Dong Chen Li, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|October 17, 2017
Homogeneity of Aerosol Deposition and Mucociliary Clearance are Improved Following Ivacaftor Treatment in Cystic FibrosisWilliam D Bennett, Kirby L Zeman, Beth L Laube, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 1, 2015
Inhaled alpha1-proteinase inhibitor therapy in patients with cystic fibrosisAmit Gaggar, Junliang Chen, James F Chmiel, et al.
Journal of Aerosol Medicine and Pulmonary Drug Delivery|February 4, 2017
A Trans-Nasal Aerosol Delivery Device for Efficient Pulmonary DepositionKirby L Zeman, Juan Rojas Balcazar, Fred Fuller, et al.
Journal of Palliative Medicine|June 30, 2021
Development of an Advance Care Planning Protocol in a Cystic Fibrosis Outpatient ClinicSarah H Todd, Elizabeth A Sonntag, Marianne L Buchanan, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 17, 2020
A four week trial of hypertonic saline in children with mild cystic fibrosis lung disease: Effect on mucociliary clearance and clinical outcomesScott H Donaldson, T Danielle Samulski, Caroline LaFave, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 23, 2009
SPLUNC1 regulates airway surface liquid volume by protecting ENaC from proteolytic cleavageAgustin Garcia-Caballero, Julia E Rasmussen, Erol Gaillard, et al.
Journal of Clinical Medicine|October 27, 2022
Dynamic Perfluorinated Gas MRI Shows Improved Lung Ventilation in People with Cystic Fibrosis after Elexacaftor/Tezacaftor/Ivacaftor: An Observational StudyJennifer L Goralski, Sang Hun Chung, Agathe S Ceppe, et al.
American Journal of Respiratory and Critical Care Medicine|September 21, 2017
Tezacaftor/Ivacaftor in Subjects with Cystic Fibrosis and F508del/F508del-CFTR or F508del/G551D-CFTRScott H Donaldson, Joseph M Pilewski, Matthias Griese, et al.
Pageof 7